Literature DB >> 6695603

Psychiatric complications of levodopa therapy of Parkinson's disease.

P A Nausieda, R Glantz, S Weber, R Baum, H L Klawans.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6695603

Source DB:  PubMed          Journal:  Adv Neurol        ISSN： 0091-3952


× No keyword cloud information.
  11 in total

1.  Hallucinations, dreaming, and frequent dozing in Parkinson disease: impact of right-hemisphere neural networks.

Authors:  Karina Stavitsky; Patrick McNamara; Raymon Durso; Erica Harris; Sanford Auerbach; Alice Cronin-Golomb
Journal:  Cogn Behav Neurol       Date:  2008-09       Impact factor: 1.600

2.  Salsolinol, catecholamine metabolites, and visual hallucinations in L-dopa treated patients with Parkinson's disease.

Authors:  A Moser; F Siebecker; P Vieregge; P Jaskowski; D Kömpf
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

Review 3.  Neuropsychiatric adverse effects of antiparkinsonian drugs. Characteristics, evaluation and treatment.

Authors:  B K Young; R Camicioli; L Ganzini
Journal:  Drugs Aging       Date:  1997-05       Impact factor: 3.923

Review 4.  Drug-induced sleep disturbances. Focus on nonpsychotropic medications.

Authors:  M Novak; C M Shapiro
Journal:  Drug Saf       Date:  1997-02       Impact factor: 5.606

5.  Peduncular hallucinosis: a syndrome of impaired reality monitoring.

Authors:  Thomas Benke
Journal:  J Neurol       Date:  2006-09-27       Impact factor: 4.849

6.  Prospective study of hallucinations and delusions in Parkinson's disease.

Authors:  S Holroyd; L Currie; G F Wooten
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-06       Impact factor: 10.154

Review 7.  Psychiatric aspects of Parkinson's disease--an update.

Authors:  Anette Schrag
Journal:  J Neurol       Date:  2004-07       Impact factor: 4.849

Review 8.  Visual hallucinations in the elderly associated with the use of levodopa.

Authors:  A K Banerjee; P G Falkai; M Savidge
Journal:  Postgrad Med J       Date:  1989-06       Impact factor: 2.401

Review 9.  Treatment of the sleep disorders associated with Parkinson's disease.

Authors:  Lynn Marie Trotti; Donald L Bliwise
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

10.  Psychiatric side effects of medications prescribed in internal medicine.

Authors:  Rodrigo Casagrande Tango
Journal:  Dialogues Clin Neurosci       Date:  2003-06       Impact factor: 5.986
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.